Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
USRE38743E1 · kind E1 · reissue
42Cited by
14References
31Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 7, 2003 |
| Grant date | Jun 14, 2005 |
| Priority date | — |
| Expiry date | May 7, 2023 |
Classification
- Technology area (CPC —)General
Abstract
Heterogeneous intimate admixtures of sulfated heparinic polysaccharides, well suited for the prophylaxis/treatment of acute thrombotic episodes in a human patient, comprise immixture of sulfated polysaccharides having a weight average molecular weight less than that of heparin and which include from 9% to 20% of polysaccharide chains having a molecular weight less than 2,000 daltons and from 5% to 20% of polysaccharide chains having a molecular weight greater than 8,000 daltons, the ratio between the weight average molecular weight and the number average molecular weight thereof ranging from 1.3 to 1.6.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.